188 related articles for article (PubMed ID: 12186633)
41. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
[TBL] [Abstract][Full Text] [Related]
42. Semisynthesis of membrane-attached prion proteins.
Chu NK; Becker CF
Methods Enzymol; 2009; 462():177-93. PubMed ID: 19632475
[TBL] [Abstract][Full Text] [Related]
43. Fragmentation and dimerization of copper-loaded prion protein by copper-catalysed oxidation.
Shiraishi N; Inai Y; Bi W; Nishikimi M
Biochem J; 2005 Apr; 387(Pt 1):247-55. PubMed ID: 15554874
[TBL] [Abstract][Full Text] [Related]
44. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
45. Interactions of bovine viral diarrhoea virus glycoprotein E(rns) with cell surface glycosaminoglycans.
Iqbal M; Flick-Smith H; McCauley JW
J Gen Virol; 2000 Feb; 81(Pt 2):451-9. PubMed ID: 10644844
[TBL] [Abstract][Full Text] [Related]
46. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein.
Hornshaw MP; McDermott JR; Candy JM
Biochem Biophys Res Commun; 1995 Feb; 207(2):621-9. PubMed ID: 7864852
[TBL] [Abstract][Full Text] [Related]
47. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
Kenward AG; Bartolotti LJ; Burns CS
Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
[TBL] [Abstract][Full Text] [Related]
48. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
49. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
50. Variation in Chst8 gene expression level affects PrPC to PrPSc conversion efficiency in prion-infected Mov cells.
Martin R; Chantepie S; Chapuis J; Le-Duc A; Maftah A; Papy-Garcia D; Laude H; Petit JM; Gallet PF
Biochem Biophys Res Commun; 2011 Oct; 414(3):587-91. PubMed ID: 21982770
[TBL] [Abstract][Full Text] [Related]
51. Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.
Baud'huin M; Ruiz-Velasco C; Jego G; Charrier C; Gasiunas N; Gallagher J; Maillasson M; Naggi A; Padrines M; Redini F; Duplomb L; Heymann D
Eur J Cell Biol; 2011 Jan; 90(1):49-57. PubMed ID: 20970218
[TBL] [Abstract][Full Text] [Related]
52. Targeting prion propagation using peptide constructs with signal sequence motifs.
Söderberg KL; Guterstam P; Langel U; Gräslund A
Arch Biochem Biophys; 2014 Dec; 564():254-61. PubMed ID: 25447819
[TBL] [Abstract][Full Text] [Related]
53. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
Park YG; Moon JH; Park SY
Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
[TBL] [Abstract][Full Text] [Related]
54. Receptors on lymphocytes for endogenous splenic glycosaminoglycans.
Bradbury MG; Parish CR
Immunology; 1989 Apr; 66(4):546-53. PubMed ID: 2541072
[TBL] [Abstract][Full Text] [Related]
55. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin.
Mann DM; Romm E; Migliorini M
J Biol Chem; 1994 Sep; 269(38):23661-7. PubMed ID: 8089135
[TBL] [Abstract][Full Text] [Related]
56. Structural Features of Heparin and Its Interactions With Cellular Prion Protein Measured by Surface Plasmon Resonance.
Kim SY; Zhang F; Harris DA; Linhardt RJ
Front Mol Biosci; 2020; 7():594497. PubMed ID: 33324681
[TBL] [Abstract][Full Text] [Related]
57. Glycosaminoglycans bind human IL-27 and regulate its activity.
Cavé MC; Maillard S; Hildenbrand K; Mamelonet C; Feige MJ; Devergne O
Eur J Immunol; 2020 Oct; 50(10):1484-1499. PubMed ID: 32483835
[TBL] [Abstract][Full Text] [Related]
58. Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.
Zhang F; Aguilera J; Beaudet JM; Xie Q; Lerch TF; Davulcu O; Colón W; Chapman MS; Linhardt RJ
Biochemistry; 2013 Sep; 52(36):6275-85. PubMed ID: 23952613
[TBL] [Abstract][Full Text] [Related]
59. A dot blot assay for sulfated glycosaminoglycans.
Scheerer J; Matzenauer C; Kreger S; Muhn P
J Biochem Biophys Methods; 1989 May; 18(3):221-6. PubMed ID: 2659649
[TBL] [Abstract][Full Text] [Related]
60. Widespread use of
Martín C; Escobedo S; Suárez JE; Quirós LM
Benef Microbes; 2019 Apr; 10(4):463-472. PubMed ID: 30882241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
